ClassID:

91575

C07C47/575 - CPC Classification

Classification description:

Compounds having —CHO groups; Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups

Sub-classes:
Recent Application in this class:
#1
20250346549
2025-11-13

NOVEL AROMATIC MOLECULES

#2
20250084023
2025-03-13

NOVEL AROMATIC MOLECULES

#3
20240140895
2024-05-02

NOVEL AROMATIC MOLECULES

#4
20230219922
2023-07-13

PROCESS FOR SYNTHESIZING 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)-PYRIDIN-3-YL)METHOXY)BENZALDEHYDE

#5
20230104617
2023-04-06

COMPOUND FOR TREATING ALZHEIMERS DISEASE

#6
20220396583
2022-12-15

COMPOUNDS AS MODULATORS OF TLR2 SIGNALING

#7
20220304958
2022-09-29

SMALL MOLECULE INHIBITORS OF A PROTEIN COMPLEX

#8
20220251016
2022-08-11

Catalyst system for olefin polymerization and use thereof

#9
20220135533
2022-05-05

PROCESS FOR SYNTHESIZING 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)-PYRIDIN-3-YL)METHOXY)BENZALDEHYDE

#10
20210347749
2021-11-11

P62 ligand compound, and composition for preventing, ameliorating or treating proteinopathies comprising the same

#11
20210299253
2021-09-30

AUTOTAC chimeric compound, and composition for preventing, ameliorating or treating diseases through targeted protein degradation comprising the same

#12
20210284623
2021-09-16

PROCESS FOR SYNTHESIZING 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)-PYRIDIN-3-YL)METHOXY)BENZALDEHYDE

#13
20210163399
2021-06-03

NOVEL P62 LIGAND COMPOUND, AND COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING PROTEINOPATHIES COMPRING THE SAME

#14
20210040033
2021-02-11

Process for preparing safinamide

#15
20210040031
2021-02-11

Process for the preparation of safinamide mesylate intermediate

#16
20210024539
2021-01-28

Compounds as modulators of TLR2 signaling

#17
20200270220
2020-08-27

Ascochlorin derivative and use thereof as AMPK activator

#18
20200181055
2020-06-11

3,6-dichlorosalicylic acid compounds and related synthetic processes

#19
20190308957
2019-10-10

Aromatic acetylene or aromatic ethylene compound, intermediate, preparation method, pharmaceutical composition and use thereof

#20
20190209592
2019-07-11

BICYCLIC ARYL SPHINGOSINE 1-PHOSPHATE ANALOGS

#21
20190161426
2019-05-30

Method for the preparation of a partially hydrogenated polyacene and an intermediate thereof

#22
20190106404
2019-04-11

Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde

#23
20190099747
2019-04-04

NANO-TO-NANO FE/PPM Pd CATALYSIS OF CROSS-COUPLING REACTIONS IN WATER

#24
20190031589
2019-01-31

Process for preparation of prostacyclin derivatives

#25
20190031588
2019-01-31

NEW VANILLIN AND OR ETHYLVANILLIN, PROCESS FOR THEIR PREPARATIONS AND USE THEREOF

#26
20190029255
2019-01-31

N-cycloalkyl-N-{[2-(1-substitutedcycloalkyl)phenyl]methylene}-(thio)carboxamide derivatives

#27
20180312523
2018-11-01

Propionic acid derivatives and methods of use thereof

#28
20180230398
2018-08-16

PERFUME SYSTEMS

#29
20180162867
2018-06-14

Eis inhibitors

#30
20180133233
2018-05-17

Bicyclic aryl sphingosine 1-phosphate analogs

#31
20180111929
2018-04-26

COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR

#32
20170334819
2017-11-23

Mild catalytic reduction of C—O bonds and C═O bonds using a recyclable catalyst system

#33
20170327484
2017-11-16

Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde

#34
20170239280
2017-08-24

Bicyclic aryl sphingosine 1-phosphate analogs

#35
20170226317
2017-08-10

Polarizing plate protective film, polarizing plate, and display device

#36
20170197898
2017-07-13

Synthesis of intermediate for treprostinil production

#37
20170162789
2017-06-08

Compound for organic light-emitting device, cross-linked material thereof, and organic light-emitting device including cross-linked material

#38
20170036969
2017-02-09

NITRIFICATION INHIBITORS

#39
20160326120
2016-11-10

N-cycloalkyl-N-{[2-(1-substitutedcycloalkyl)phenyl]methylene}-(thio)carboxamide derivatives

#40
20160316752
2016-11-03

N-cycloalkyl-N-{[2-(1-substitutedcycloalkyl)phenyl]methylene}-(thio)carboxamide derivatives

#41
20160296494
2016-10-13

Dihydroorotic and acid dehydrogenase inhibitor

#42
20160289593
2016-10-06

PERFUME SYSTEMS

#43
20160177222
2016-06-23

IONIC LIQUID SYSTEMS

#44
20160168116
2016-06-16

IRE-1α inhibitors

#45
20160129023
2016-05-12

Bicyclic aryl sphingosine 1-phosphate analogs

#46
20160068461
2016-03-10

Synthesis of intermediate for treprostinil production

#47
20160039801
2016-02-11

Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation

#48
20150361030
2015-12-17

PERFLUOROPOLYVINYL MODIFIED ARYL INTERMEDIATES AND MONOMERS

#49
20150203459
2015-07-23

Process for the preparation of (2Z,5Z)-5-(3-chloro-4-(()-2,3-dihydroxypropdxy)benzylidene)-2-(propylimino)-3-(-tolyl)thiazolidin-4-one and intermediate used in said process

#50
20150126761
2015-05-07

Process for the preparation of treprostinil and derivatives thereof

#51
20140309190
2014-10-16

Bicyclic aryl sphingosine 1-phosphate analogs

#52
20140135518
2014-05-15

Perfluoropolyvinyl modified aryl intermediates and monomers

#53
20140080832
2014-03-20

IRE-1α inhibitors

#54
20130345471
2013-12-26

SYNTHESIS OF INTERMEDIATE FOR TREPROSTINIL PRODUCTION

#55
20130303572
2013-11-14

Inhibitors of matrix metalloproteinases

#56
20130296422
2013-11-07

Dihydroxybenzene derivatives and antiprotozoal agent comprising same as active ingredient

#57
20130211145
2013-08-15

Protected aldehydes for use as intermediates in chemical syntheses, and processes for their preparation

#58
20130101509
2013-04-25

IMAGING AND RADIOTHERAPY METHODS

#59
20130018194
2013-01-17

OCTAHYDROBINAPHTHOL DERIVATIVE FOR L/D OPTICAL CONVERSION AND OPTICAL RESOLUTION

#60
20130005766
2013-01-03

5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents

#61
20120277321
2012-11-01

METHOD FOR PREPARING A COMPOSITION COMPRISING A COMPOUND BASED ON VANILLIN AND ETHYL VANILLIN, RESULTING COMPOSITION AND USES THEREOF

#62
20120232279
2012-09-13

Mild and selective vanadium-catalyzed oxidation of benzylic, allylic, and propargylic alcohols using air

#63
20120226076
2012-09-06

Synthesis of intermediate for treprostinil production

#64
20120220792
2012-08-30

Process for producing aldehydes or ketones by oxidizing alcohols with oxygen

#65
20120190649
2012-07-26

Bicyclic aryl sphingosine 1-phosphate analogs

#66
20120103786
2012-05-03

Separation of aromatic aldehydes

#67
20120071672
2012-03-22

Process for preparing aromatic aldehyde compound

#68
20120059188
2012-03-08

Halogenated analogues of anti-fibrotic agents

#69
20120058172
2012-03-08

PLANT EXTRACTS FOR USE IN BRAIN MODULATION

#70
20120053177
2012-03-01

COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR

#71
20120046255
2012-02-23

Non-steroidal compounds

#72
20120022098
2012-01-26

Compounds and methods for kinase modulation, and indications therefor

#73
20110245544
2011-10-06

Process for preparing hydroxy-substituted aromatic aldehydes

#74
20110230565
2011-09-22

Compounds including vanillin and ethylvanillin and methods of making and using the same

#75
20110124679
2011-05-26

2-substituted--quinone derivatives for treatment of oxidative stress diseases

#76
20110098489
2011-04-28

Process for production of benzaldehyde compound

#77
20110092591
2011-04-21

PHENYL-PRENYL DERIVATIVES, OF MARINE AND SYNTHETIC ORIGIN, FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS

#78
20110071178
2011-03-24

Methods and Compounds for Modulating Cannabinoid Activity

#79
20110065162
2011-03-17

IRE-1α inhibitors

#80
20110059963
2011-03-10

Compounds and methods for kinase modulation, and indications therefor

#81
20110039874
2011-02-17

MONOACYLGLYCEROL LIPASE INHIBITORS FOR MODULATION OF CANNABINOID ACTIVITY

#82
20110021815
2011-01-27

Halogenated analogues of anti-fibrotic agents

#83
20110021613
2011-01-27

PLANTS EXTRACTS FOR USE IN BRAIN MODULATION

#84
20100323999
2010-12-23

Therapeutic Molecules and Methods-1

#85
20100292513
2010-11-18

Process for production of benzaldehyde compound

#86
20100256365
2010-10-07

Compounds and methods for kinase modulation, and indications therefor

#87
20100249165
2010-09-30

PDZ DOMAIN MODULATORS

#88
20100249118
2010-09-30

Compounds and methods for kinase modulation, and indications therefor

#89
20100249075
2010-09-30

Substituted tetralins as selective estrogen receptor-β agonists

#90
20100234645
2010-09-16

Method for producing benzaldehyde compound

#91
20100217027
2010-08-26

PROCESS FOR PRODUCTION PHENOL DERIVATIVES SUBSTITUTED WITH IODINE AT ORTHO POSITION

#92
20100210879
2010-08-19

Method for producing benzaldehyde compound

#93
20100204038
2010-08-12

Catalysts based on metal complexes for the synthesis of optically active chrysanthemic acid

#94
20100145060
2010-06-10

Schwartz reagents: methods of in situ generation and use

#95
20100113835
2010-05-06

Method for producing optically active aziridine compounds and amine compounds as well as complexes and their intermediates used in this method

#96
20100113815
2010-05-06

Method for producing optically active aziridine compounds and amine compounds as well as complexes and their intermediates used in this method

#97
20100087651
2010-04-08

NEW MANDELIC ACID DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS

#98
20100081782
2010-04-01

Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same

#99
20100068139
2010-03-18

Methods of radiofluorination of biologically active vectors

#100
20100056799
2010-03-04

Stable isotope-labeled aromatic amino acids, method for incorporating the same in target protein and method for NMR-structural analysis of proteins

#101
20100048920
2010-02-25

Preparation of (+)-Catechin, (-)-Epicatechin, (-)-Catechin, and (+)-Epicatechin and Their 5,7,3',4'-Tetra-O-Benzyl Analogues

#102
20100048893
2010-02-25

Substituted arylalkanoic acid derivatives and use thereof

#103
20090326263
2009-12-31

Process for the preparation of aniline-derived thyroid receptor ligands

#104
20090326018
2009-12-31

2-Phenyl indene derivatives useful as estrogen receptor ligands

#105
20090312315
2009-12-17

PAI-1 inhibitor

#106
20090306016
2009-12-10

Fatty acid amide hydrolase inhibitors

#107
20090281146
2009-11-12

PROCESS FOR THE PREPARATION OF N-(3,5-DICHLOROPYRID-4-YL)-4-DIFLUOROMETHOXY-8-METHANESULFONAMIDO-DIBENZO[B,D]FURAN-1-CARBOXAMIDE

#108
20090275664
2009-11-05

NOVEL POLYAMINE ANALOG CONJUGATES AND QUINONE CONJUGATES AS THERAPIES FOR CANCERS AND PROSTATE DISEASES

#109
20090233930
2009-09-17

Novel 2-Amino-Imidazole-4-One Compounds and Their Use in the Manufacture of a Medicament to Be Used in the Treatment of Cognitive Impairment, Alzheimer's Disease, Neurodegeneration and Dementia

#110
20090186893
2009-07-23

IRE-1α inhibitors

#111
20090176305
2009-07-09

Compounds and methods for treating breast cancer and other diseases

#112
20090137564
2009-05-28

5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents

#113
20090131530
2009-05-21

4-(or 5-) substituted catechol derivatives

#114
20090118546
2009-05-07

Methods for stabilizing lithiated halogen-substituted aromatic compounds

#115
20090118498
2009-05-07

Ozonolysis reactions in liquid COand CO-expanded solvents

#116
20090105319
2009-04-23

Naphthalene-based inhibitors of anti-apoptotic proteins

#117
20090062569
2009-03-05

Process for preparing 3,4-dioxo-substituted aromatic aldehydes

#118
20090062530
2009-03-05

Substituted arylalkanoic acid derivatives and use thereof

#119
20090042957
2009-02-12

Substituted Oxyarenes

#120
20090018369
2009-01-15

Process for preparing erianin

#121
20080305976
2008-12-11

Color-Stabilization of Aromachemicals

#122
20080293718
2008-11-27

Novel 2-Amino-Imidazole-4-One Compounds and Their Use in the Manufacture of a Medicament to Be Used in the Treatment of Cognitive Impairment, Alzheimer's Disease, Neurodegeneration and Dementia

#123
20080275008
2008-11-06

Aminophosphonic acid derivative, salt thereof, and modulator of S1P receptor

#124
20080194697
2008-08-14

NOVEL POLYAMINE ANALOG CONJUGATES AND QUINONE CONJUGATES AS THERAPIES FOR CANCERS AND PROSTATE DISEASES

#125
20080188691
2008-08-07

Process for the preparation of aromatic aldehydes

#126
20080167378
2008-07-10

Receptor function regulating agent

#127
20080146778
2008-06-19

Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same

#128
20080108849
2008-05-08

Method for preparing para-phenyl alkynyl benzaldehydes

#129
20080090800
2008-04-17

Mandelic acid derivatives and their use as thrombin inhibitors

#130
20080081916
2008-04-03

Method for producing optically active aziridine compounds and amine compounds as well as complexes and their intermediates used in this method

#131
20080051596
2008-02-28

6-(poly-substituted aryl)-4-aminopicolinates and their use as herbicides

#132
20080045734
2008-02-21

6-(poly-substituted aryl)-4-aminopicolinates and their use as herbicides

#133
20080033171
2008-02-07

Ligands for metals and improved metal-catalyzed processes based thereon

#134
20080021237
2008-01-24

Catalysts based on metal complexes for the synthesis of optically active chrysanthemic acid

#135
20070219380
2007-09-20

Dibenzofuran derivatives, dibenzothiophene derivatives and fluorene derivatives

#136
20070218136
2007-09-20

New mandelic acid derivatives and their use as thrombin inhibitors

#137
20070213333
2007-09-13

Substituted arylalkanoic acid derivatives and use thereof

#138
20070212267
2007-09-13

Method and apparatus for performing micro-scale chemical reactions

#139
20070208086
2007-09-06

UBIQUINONE ANALOGS AND METHODS OF USE

#140
20070208078
2007-09-06

Phenol derivatives and antitrypanosoma preventive/therapeutic agent comprising the same as active ingredient

#141
20070203224
2007-08-30

SMALL-MOLECULES FOR TREATING CANCER AND ABNORMAL CELL PROLIFERATION DISORDERS

#142
20070203080
2007-08-30

New Drug Delivery System for Crossing the Blood Brain Barrier

#143
20070202174
2007-08-30

Mandelic acid derivatives and their use as thrombin inhibitors

#144
20070179060
2007-08-02

6-(poly-substituted aryl)-4-aminopicolinates and their use as herbicides

#145
20070161692
2007-07-12

Conformationally restricted polyamine analogs as disease therapies

#146
20070142427
2007-06-21

Noncyclic 1,3-Dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity

#147
20070093476
2007-04-26

Novel compounds and their use in medicine,as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them

#148
20070049773
2007-03-01

Process for functionalising a phenolic compound carrying an electron-donating group

#149
20070004934
2007-01-04

Process for producing aromatic aldehyde

#150
20070004922
2007-01-04

Process for the ruthenium-catalysed oxidation of alcohols by means of hypochlorite

#151
20060264500
2006-11-23

Flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents

#152
20060257330
2006-11-16

Powdery pharmaceutical compositions for inhalation

#153
20060235073
2006-10-19

Diamino-functional chalcones

#154
20060194328
2006-08-31

Stable isotope-labeled aromatic amino acids, method for incorporating the same in target protein and method for NMR-structural analysis of proteins

#155
20060189549
2006-08-24

Chalcone derivatives and their use to treat diseases

#156
20060178356
2006-08-10

Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods

#157
20060167234
2006-07-27

Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same

#158
20060160771
2006-07-20

Aminophosphonic acid derivatives, addition salts thereof and S1P receptor modulators

#159
20060154977
2006-07-13

Therapeutic molecules and methods-1

#160
20060135779
2006-06-22

Process for the preparation N-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methane sulfonamido-dibenzo[b,d]furan-1-carboxamide

#161
20060128957
2006-06-15

Fluorous tagging and scavenging reactants and methods of synthesis and use thereof

#162
20060122434
2006-06-08

Oxidation method of primary or secondary alcohol

#163
20060111445
2006-05-25

Carboxylic acids and derivatives for the treatment of and preventing diabetes and dyslipidaemia

#164
20060106102
2006-05-18

Napththalene derivatives which inhibit the cytokine or biological activity of microphage migration inhibitory factor (mif)

#165
20060069257
2006-03-30

Ligands for metals and improved metal-catalyzed processes based thereon

#166
20060052600
2006-03-09

Amino-functional chalcones

#167
20060041003
2006-02-23

Estrogen receptor modulators

#168
20060035868
2006-02-16

Functionalized stilbene derivatives as improved vascular targeting agents

#169
20050233943
2005-10-20

Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases

#170
20050228199
2005-10-13

Method for preparing 3-cyclopentyloxy-4-methoxybenzaldehyde

#171
20050227990
2005-10-13

Aminoalkoxy-functional chalcones

#172
20050214952
2005-09-29

Oligo(p-phenylene vinylene) amphiphiles and methods for self-assembly

#173
20050203180
2005-09-15

Cinnamic acid dimers, their preparation and the use thereof for treating neurodegenerative disease

#174
20050142155
2005-06-30

Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods

#175
20050137410
2005-06-23

Practical, cost-effective synthesis of CoQ10

#176
20050130221
2005-06-16

Synthesis for the preparation of compounds for screening as potential tubulin binding agents

#177
20050113416
2005-05-26

Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods

#178
20050096384
2005-05-05

Compounds and methods for treating breast cancer and other diseases

#179
20050054873
2005-03-10

Process for the preparation of aniline-derived thyroid receptor ligands

#180
20050054632
2005-03-10

Naphthyl compounds, intermediates, compositions, and methods of use

#181
20050032753
2005-02-10

Substituted phenol compounds useful for anesthesia and sedation

#182
20050010060
2005-01-13

Quinones as disease therapies

#183
20050003954
2005-01-06

Photocatalyst

#184
18655571
2025-02-04

4,4′-[(2-hydroxypropane-1,3-diyl)bis(oxy)]dibenzaldehyde as an eco-friendly insecticidal agent against (boisd.)